Bridgeway Capital Management’s Q32 Bio QTTB Stock Holding History

Bridgeway Capital Management’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$441K	Buy	34,613 +22,000	+174%	+$184K	0.01%	878
2026 Q1	$81K	Buy	+12,613	New	+$59.9K	﹤0.01%	1150
2023 Q4	–	Sell	-10,283	Closed	-$217K	–	1427
2023 Q3	$217K	Buy	10,283 +1,666	+19%	+$34K	0.01%	1085
2023 Q2	$137K	Sell	8,617 -4,166	-33%	-$74.8K	﹤0.01%	1206
2023 Q1	$237K	Buy	12,783 +311	+2%	+$7.75K	0.01%	1074
2022 Q4	$283K	Buy	12,472 +1,389	+13%	+$36.9K	0.01%	1002
2022 Q3	$321K	Buy	11,083 +5,555	+100%	+$227K	0.01%	1017
2022 Q2	$196K	Sell	5,528 -2,778	-33%	-$94.8K	﹤0.01%	1093
2022 Q1	$454K	Buy	+8,306	New	+$516K	0.01%	961

Other funds holding QTTB

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

AVLSA

Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

SummitTX Capital Fort Worth, Texas $3.89B AUM 55.94% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Bridgeway Capital Management's QTTB Position: Q2 2026 in Review

Bridgeway Capital Management increased its Q32 Bio (QTTB) stake by 174% in Q2 2026, buying an estimated $184K and bringing the position to 34,613 shares worth $441K. The position accounts for 0.01% of the portfolio, ranked #878.

Bridgeway Capital Management first reported a position in QTTB in Q1 2022 and has held it in 9 quarters since. The position peaked at $454K in Q1 2022. 72 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.

Bridgeway Capital Management held 34,613 shares of Q32 Bio worth $441K as of Q2 2026.
Bridgeway Capital Management bought 22,000 Q32 Bio shares in Q2 2026, an estimated $184K.
Q32 Bio made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #878 holding.
Bridgeway Capital Management first reported a position in Q32 Bio in Q1 2022 and has held it in 9 quarters since.
Bridgeway Capital Management's Q32 Bio position peaked at $454K in Q1 2022.
72 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.